Literature DB >> 3379347

Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high performance liquid chromatography.

T A Hughes1, M A Moore, P Neame, M F Medley, B H Chung.   

Abstract

A new methodology for the analysis of lipoprotein composition using a combination of gradient ultracentrifugation and high performance liquid chromatography was used to determine the differences in lipoprotein composition between non-hyperlipidemic men and women. Lipoproteins from each subject were separated into six subfractions: VLDL, IDL, LDL, and three subfractions of HDL by a single gradient ultracentrifugation spin of less than 5 hr. The HDL subfractions were designated HDL-L (the lightest density subfraction, rich in apoCs and poor in apoA-II), HDL-M (the middle subfraction, rich in apoA-II), and HDL-D (the most dense, relatively poor in both the apoCs and apoA-II). The concentrations of the water-soluble apolipoproteins in each subfraction were determined using reversed-phase HPLC. The concentrations of apoB and the lipid components of the lipoproteins were determined by chemical and enzymatic methods. This methodology proved to be highly reproducible when performed on fresh plasma samples and we were able to identify many sex-associated differences in lipoprotein composition. This methodology is the only nonimmunological technique available for analyzing lipoprotein composition that offers such a combination of accuracy, speed, and completeness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379347

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  2 in total

1.  Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.

Authors:  Thomas A Hughes; Frankie Stentz; Thomas Gettys; Steven R Smith
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

2.  Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.

Authors:  Priscila Camillo Teixeira; Axel Ducret; Philippe Ferber; Hubert Gaertner; Oliver Hartley; Sabrina Pagano; Michelle Butterfield; Hanno Langen; Nicolas Vuilleumier; Paul Cutler
Journal:  J Biol Chem       Date:  2014-08-28       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.